Navigation Links
Contract Services for Big Pharma and Biotechs Driving Growth and Innovation from Discovery to Clinical Trials
Date:2/6/2008

NEW YORK, Feb. 6 /PRNewswire/ -- Over the past few years, the strategic importance of the global pharmaceutical marketplace has become increasingly apparent. Multinational interest and investment in the global pharmaceutical industry is at an all-time high and competition is heating up. On one hand big pharma is pumping in more resources into outsourcing and offshoring. On the other hand, drug safety issues, threat from biogenerics, stricter protocols for APIs and pharmacovigilance issues question some existing models and frameworks. More than ever, as the demand intensifies to fill the pharmaceutical pipeline with new drugs and therapeutics -- outsourcing partnerships are playing an increasingly critical role.

The 2008 BioPharma Outsourcing: Partnerships with CROs and Other Service Providers forum, scheduled for March 25-26, 2008 at the Hilton Boston Back Bay in Boston, MA is designed to bring together pharma and biotech executives from around the world to gather strategic information and creating networking relationships all eager to facilitate new investments and partnerships.
Distinguished Speaker Roster Includes (updated as of February 6, 2008):

-- Diana M. Galer Ph.D., VP, Strategic Management Group, Pfizer Global

Research & Development

-- Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam

Pharmaceuticals

-- RoseAnn Price, Alliance Management, Amgen

-- Mel Sorensen, M.D., President & CEO, Ascenta Therapeutics, Inc.

-- Ahsan Awan, JD, MBA, CRCP, Global CINRG, Inc.

-- Gur Roshwalb, MD, VP & Senior Analyst Health Care, Piper Jaffray

& Co.

-- Han Gunn, Preclinical Director, Department of Pharmacokinetics & Drug

Metabolism, Amgen

-- Partha S. Ray, MD, CEO, IndusPharma Consulting Group

-- Michael Palladino, PhD, Senior VP, CTO, & Scientific Co-Founder,

Nereus Pharmaceuticals

-- Steve J. Bannister, PhD, Chief Scientific Officer, Xcelience, LLC

-- Judd Berman, PhD., Chief Scientific Officer, Dalton Medicinal

Chemistry

-- Zhengming (Jimmy) Chen, PhD, Senior Director, Chemistry and CMC,

DOV Pharmaceutical, Inc.

-- John Lemelan, General Partner, Riverside Partners

-- Dean Wilson, PhD, Research Fellow, Vertex Pharmaceuticals

-- John Maclennan, PhD, Director, Business Development, Wolfe

Laboratories, Inc.

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0803

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
2. DNA is blueprint, contractor and construction worker for new structures
3. Clinimetrics Celebrates 20th Anniversary in Contract Research Business
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
6. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
7. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
8. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
9. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
10. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
11. ICx Awarded Department of Defense Contract for AirSentinel Monitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
(Date:6/23/2016)... ReportsnReports.com adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):